Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study

Background. Hypertension as a major risk factor for cardiovascular diseases is among the leading causes of death worldwide. The relationship between elevated serum levels of liver enzymes and hypertension has been reported in limited studies, and to the best of our knowledge, there are no previous r...

Full description

Saved in:
Bibliographic Details
Main Authors: Parvin Khalili, Saeedeh Abdollahpoor, Fatemeh Ayoobi, Alireza Vakilian, Hamid Hakimi, Zohreh Rajabi, Zahra Jamali
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2022/5062622
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565880477712384
author Parvin Khalili
Saeedeh Abdollahpoor
Fatemeh Ayoobi
Alireza Vakilian
Hamid Hakimi
Zohreh Rajabi
Zahra Jamali
author_facet Parvin Khalili
Saeedeh Abdollahpoor
Fatemeh Ayoobi
Alireza Vakilian
Hamid Hakimi
Zohreh Rajabi
Zahra Jamali
author_sort Parvin Khalili
collection DOAJ
description Background. Hypertension as a major risk factor for cardiovascular diseases is among the leading causes of death worldwide. The relationship between elevated serum levels of liver enzymes and hypertension has been reported in limited studies, and to the best of our knowledge, there are no previous reports in the literature on this issue in the southeast of Iran. Our investigation aimed at evaluating the relation between ALT, AST, GGT, and ALP with hypertension in the Rafsanjan Cohort Study, a city in Kerman Province, Iran. Methods. In this cross-sectional study, we used data obtained from the Rafsanjan Cohort Study (RCS), as a part of the prospective epidemiological research studies in Iran (PERSIAN). The association of the liver enzymes levels with hypertension was investigated using the multivariable logistic regression models. Results. Among 9930 participants, the mean age (±SD) was 49.94 (±9.56) years, and 46.56% were men. The odds of abnormal blood pressure significantly increased along with the higher levels of ALT, GGT, and ALP which remained significant only for ALP after adjustment for all confounding variables in both males and females (OR in males: 1.36, 95% CI = 1.09–1.69, OR in females: 1.25, 95% CI = 1.01–1.54). In subjects with normal levels of ALT, AST, GGT, and ALP, dose-response increases were observed for abnormal blood pressure in both genders. Finally, we found that, among liver enzymes, only elevated ALP was significantly correlated with the odds of stage 1 hypertension and stage 2 hypertension for both genders. Conclusions. In subjects with normal levels of ALT, AST, GGT, and ALP, dose-response increases were observed for abnormal blood pressure in both genders. Increased serum ALP activity was positively associated with increased odds of hypertension in males and females. Therefore, increased ALP could be an early indicator of hypertension.
format Article
id doaj-art-bc1493210f334cd689127d362b1fa9a0
institution Kabale University
issn 2090-0392
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series International Journal of Hypertension
spelling doaj-art-bc1493210f334cd689127d362b1fa9a02025-02-03T01:06:32ZengWileyInternational Journal of Hypertension2090-03922022-01-01202210.1155/2022/5062622Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort StudyParvin Khalili0Saeedeh Abdollahpoor1Fatemeh Ayoobi2Alireza Vakilian3Hamid Hakimi4Zohreh Rajabi5Zahra Jamali6Social Determinants of Health Research CentreGrowth and Development Research CenterOccupational Safety and Health Research CenterNon-Communicable Diseases Research CenterNon-Communicable Diseases Research CenterNon-Communicable Diseases Research CenterNon-Communicable Diseases Research CenterBackground. Hypertension as a major risk factor for cardiovascular diseases is among the leading causes of death worldwide. The relationship between elevated serum levels of liver enzymes and hypertension has been reported in limited studies, and to the best of our knowledge, there are no previous reports in the literature on this issue in the southeast of Iran. Our investigation aimed at evaluating the relation between ALT, AST, GGT, and ALP with hypertension in the Rafsanjan Cohort Study, a city in Kerman Province, Iran. Methods. In this cross-sectional study, we used data obtained from the Rafsanjan Cohort Study (RCS), as a part of the prospective epidemiological research studies in Iran (PERSIAN). The association of the liver enzymes levels with hypertension was investigated using the multivariable logistic regression models. Results. Among 9930 participants, the mean age (±SD) was 49.94 (±9.56) years, and 46.56% were men. The odds of abnormal blood pressure significantly increased along with the higher levels of ALT, GGT, and ALP which remained significant only for ALP after adjustment for all confounding variables in both males and females (OR in males: 1.36, 95% CI = 1.09–1.69, OR in females: 1.25, 95% CI = 1.01–1.54). In subjects with normal levels of ALT, AST, GGT, and ALP, dose-response increases were observed for abnormal blood pressure in both genders. Finally, we found that, among liver enzymes, only elevated ALP was significantly correlated with the odds of stage 1 hypertension and stage 2 hypertension for both genders. Conclusions. In subjects with normal levels of ALT, AST, GGT, and ALP, dose-response increases were observed for abnormal blood pressure in both genders. Increased serum ALP activity was positively associated with increased odds of hypertension in males and females. Therefore, increased ALP could be an early indicator of hypertension.http://dx.doi.org/10.1155/2022/5062622
spellingShingle Parvin Khalili
Saeedeh Abdollahpoor
Fatemeh Ayoobi
Alireza Vakilian
Hamid Hakimi
Zohreh Rajabi
Zahra Jamali
Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
International Journal of Hypertension
title Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
title_full Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
title_fullStr Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
title_full_unstemmed Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
title_short Evaluation of Relationship between Serum Liver Enzymes and Hypertension: A Cross-Sectional Study Based on Data from Rafsanjan Cohort Study
title_sort evaluation of relationship between serum liver enzymes and hypertension a cross sectional study based on data from rafsanjan cohort study
url http://dx.doi.org/10.1155/2022/5062622
work_keys_str_mv AT parvinkhalili evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT saeedehabdollahpoor evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT fatemehayoobi evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT alirezavakilian evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT hamidhakimi evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT zohrehrajabi evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy
AT zahrajamali evaluationofrelationshipbetweenserumliverenzymesandhypertensionacrosssectionalstudybasedondatafromrafsanjancohortstudy